Sort   by:  
 Page size 
MALDI MSI for monitoring of drug response in primary cancer spheroids
ORGANISM(S): Homo sapiens (Human) 
2019-09-03 | PXD013069 | Pride
Although NGLY1 deficiency has been discovered as a result of mutations in the NGLY1 gene, cellular and molecular mechanisms underlying the neurological abnormalities due to NGLY1 malfunction in the brain remain mostly unknown. Using human cerebral organoid (CO) models and systems biology techniques,...
ORGANISM(S): Homo sapiens (Human) 
2022-05-20 | PXD026681 | Pride
Cloutier2009 - Brain Energy Metabolism This model was taken from the  CellML repository  and automatically converted to SBML.  Following the submission the parameters are manually encoded and annotated as spices and global quantities by BioModels curators.    The origin...
2024-09-02 | BIOMD0000000554 | BioModels
To identify a panel of m/z markers for the early detection of colorectal cancer (CRC). Identication of a molecular pattern that can distinguish the primary tumours of colorectal cancer with lymph node metastasis compared to those without. Using MALDI MSI data,we developed and validated a machine lea...
ORGANISM(S): Homo sapiens (Human) 
2022-02-15 | PXD019653 | Pride
Aim is to identify a panel of m/z markers for the early detection of colorectal cancer (CRC). Identification of a molecular pattern that can distinguish the primary tumours of colorectal cancer with lymph node metastasis compared to those without. Materials and Methods: Using MALDI MSI data, we deve...
ORGANISM(S): Homo sapiens (Human) 
2022-02-15 | PXD019662 | Pride
Ovarian cancer is still the most lethal gynecological cancer, despite advances in patients’ strati-fication and treatment. Only about 80% of patients respond to the first line of treatment and many suffer a relapse with a treatment resistant disease. Here, we have identified three potential markers ...
ORGANISM(S): Homo sapiens (Human) 
2023-05-10 | PXD033785 | Pride
Sort   by:  
 Page size